SARS-CoV-2 infection in brain tumors and the association with alterations in the tumor immune microenvironmentOA
SARS-CoV-2 infection in brain tumors and the association with alterations in the tumor immune microenvironment
Weikang Chen;Xiaoxing Li;Linyi Liu;Xiaobing Jiang;Haojie Bai;Maoling Tian;Yanxia Huang;Depei Li;Luyao Wu;Wei Li;Lei Zhou;Wange Lu
Department of Neurosurgery,State Key Laboratory of Oncology in South China,Guangdong Provincial Clinical Research Center for Cancer,Sun Yat-sen University Cancer Center,Guangzhou 510060,China||Institute of Precision Medicine,The First Affiliated Hospital,Sun Yat-sen University,Guangzhou 510000,ChinaInstitute of Precision Medicine,The First Affiliated Hospital,Sun Yat-sen University,Guangzhou 510000,ChinaDepartment of Neurosurgery,Northeast Yunnan Central Hospital,Zhaotong 657000,ChinaDepartment of Neurosurgery,State Key Laboratory of Oncology in South China,Guangdong Provincial Clinical Research Center for Cancer,Sun Yat-sen University Cancer Center,Guangzhou 510060,ChinaInstitute of Precision Medicine,The First Affiliated Hospital,Sun Yat-sen University,Guangzhou 510000,ChinaDepartment of Neurosurgery,State Key Laboratory of Oncology in South China,Guangdong Provincial Clinical Research Center for Cancer,Sun Yat-sen University Cancer Center,Guangzhou 510060,ChinaDepartment of Neurosurgery,The First Affiliated Hospital,Sun Yat-sen University,Guangzhou 510000,ChinaDepartment of Neurosurgery,State Key Laboratory of Oncology in South China,Guangdong Provincial Clinical Research Center for Cancer,Sun Yat-sen University Cancer Center,Guangzhou 510060,ChinaDepartment of Neurosurgery,State Key Laboratory of Oncology in South China,Guangdong Provincial Clinical Research Center for Cancer,Sun Yat-sen University Cancer Center,Guangzhou 510060,ChinaInstitute of Precision Medicine,The First Affiliated Hospital,Sun Yat-sen University,Guangzhou 510000,ChinaInstitute of Precision Medicine,The First Affiliated Hospital,Sun Yat-sen University,Guangzhou 510000,ChinaInstitute of Precision Medicine,The First Affiliated Hospital,Sun Yat-sen University,Guangzhou 510000,China
SARS-CoV-2brain tumorsimmune microenvironmentinnate immunecomplement activation
SARS-CoV-2brain tumorsimmune microenvironmentinnate immunecomplement activation
《癌症生物学与医学（英文版）》 2026 (5)
769-784,16
This study was supported by the National Natural Science Foundation of China(Grant Nos.82372624,82573778,and 82504174),the Guangdong Basic and Applied Basic Research Foundation(Grant No.2024A1515013102),the Guangdong Pearl River Talent Program(Grant No.2023ZT10Y094),the China Postdoctoral Science Foundation(Grant No.2022M723588),the Medical Scientific Research Foundation of Guangdong Province(Grant No.A2023439),Science and Technology Empowering Inner Mongolia Major Special Project of Inner Mongolia Autonomous Region(Grant No.2022-KJXM-ZCQ-11),and the Guangdong Basic and Applied Basic Research Foundation(Grant No.2023A1515110422).
评论